Michael H. Criqui, M.D., M.P.H., is Distinguished Professor and Chief, Division of Preventive Medicine, in the Department of Family and Preventive Medicine at the University of California, San Diego (UCSD) School of Medicine. He also holds a joint appointment as Distinguished Professor, Division of Cardiology, in the Department of Medicine at UCSD, and he is Director of the Preventive Cardiology Academic Award Program at UCSD. Dr Criqui received his medical degree and did his residency training at the University of California, San Francisco and received his Master of Public Health degree in epidemiology from the University of California, Berkeley. He is Board Certified in General Preventive Medicine by the American College of Preventive Medicine.
Dr. Criqui is an active and productive investigator in cardiovascular epidemiology and preventive cardiology, and has made seminal contributions in the fields of subclinical atherosclerosis, peripheral arterial disease, and peripheral venous disease. He has published over 425 manuscripts and book chapters, and has been an invited lecturer at numerous national and international medical meetings. He is the recipient of several research grants and contracts, and is currently the Director of the NHLBI funded training program at UCSD in cardiovascular epidemiology and prevention. He has mentored numerous students, residents and fellows.
Dr. Criqui is a Fellow of the following societies: the American College of Preventive Medicine, the American College of Epidemiology, the Society for Vascular Medicine, the Council on Peripheral Vascular Disease of the American Heart Association, and the Council on Epidemiology and Prevention of the American Heart Association, for which he served as Chair. He is past Chair of the Interdisciplinary Committee on Prevention for the American Heart Association. . He currently chairs the International Peripheral Arterial Disease Working Group, for the Global Burden of Diseases, Injuries, and Risk Factors Study. He has served on committees for the National Institutes of Health, the Food and Drug Administration, the Centers for Disease Control, the World Health Organization, and the Institute of Medicine.
He is the recipient of several honors including election to the American Epidemiological Society (1984), the Joseph E. Stokes III Preventive Cardiology Award from the American Society for Preventive Cardiology (2001), the Frederick H. Epstein Memorial Lecture Award from the European Society of Cardiology Working Group on Epidemiology and Prevention (2002), the Special Recognition Award from AHA Council on Epidemiology and Prevention (2004), the Distinguished Achievement Award from the AHA Council on Epidemiology and Prevention (2008), the President’s Award for Vision from the Vascular Disease Foundation (2010), and the Marcus Award for Distinguished Contribution as a Gifted Teacher from the International Academy of Cardiology (2011). In 2010, he was named a Distinguished Scientist of the American Heart Association, the organization’s highest scientific award.
Dr. Allison is the principal investigator for an NIH/NHLBI R01 studying the association between abdominal body composition, inflammation and cardiovascular disease and an NIH/NIDDK R01 examining the association between renal artery atherosclerosis and kidney function. He is also the PI of the subcontract for the Hispanic Centers of Excellence in Cardiovascular Disease, a co-investigator for the Multi-Ethnic Study of Atherosclerosis (MESA), the Hispanic Communities Health Study – Study of Latinos, the Alzheimer Caregivers Study, and the Venous Incidence Study. Previously, he was the PI of a Sandra Daugherty grant in Cardiovascular Epidemiology and an American Heart Association Fellow to Faculty Award.
Dr Allison is a Diplomat of the American Board of Preventive Medicine and a member of the American Heart Association’s Council on Epidemiology and Prevention. He is the past Chair of the Early Career and Minority Committees for this Council.
Cheryl A. M. Anderson, PhD, MPH, MS, is an Associate Professor in the Department of Family and Preventive Medicine. Dr. Anderson received her doctoral degree from the University of Washington, and her Master of Public Health degree from the University of North Carolina at Chapel Hill. At UCSD, Dr. Anderson is a member of the Cardiovascular Epidemiology and Prevention Center of Excellence, as well as the Health Behavior Change in Underserved and Vulnerable Populations Center of Excellence.
Dr. Anderson's research focuses on nutrition and chronic disease prevention. She is an active researcher in cardiovascular epidemiology, and is the principal investigator of an NHLBI-funded study of the effects of dietary sodium and potassium intake on cardiovascular disease. She is the also the principal investigator of a behavioral intervention study for adherence to current dietary sodium recommendations. She is a co-investigator on the NIDDK-funded national multicenter Chronic Renal Insufficiency Cohort Study, which aims to identify risk factors and mechanisms of progressive renal disease and cardiovascular events in individuals with chronic kidney disease.
Dr. Anderson is a Fellow of the American Heart Association, and is a member of the leadership committee of the American Heart Association's councils on Epidemiology and Nutrition Physical Activity and Metabolism. She is also a member of the Pan American Health Organization’s (PAHO) Expert Group on Cardiovascular Disease Prevention through Dietary Salt Reduction, and the World Health Organization’s International Agency for Research on Cancer (IARC) committee on nutrition and physical (in)activity as determinants of cancer risk in Africa. She has also served on committees of the institute of Medicine (IOM), and in 2011 was appointed to the IOM’s standing Food and Nutrition Board. Additional honors and awards include the prestigious Gil Omenn Award for Academic Excellence (2001), Dannon Nutrition Leadership Institute Scholar (2003), and a Volunteer Service Award from the National Kidney Foundation of Maryland (2010).
Dr. Fontanesi is the Director of the Center for Management Science in Health and a professor with appointment in the Departments of Pediatrics, Family and Preventive Medicine. His research is devoted to the translation of Operational Research concepts and procedures to health care.
James H. Fowler, Ph. D. earned a PhD from Harvard in 2003 and is currently Professor of Medical Genetics and Political Science at the University of California, San Diego. His work lies at the intersection of the natural and social sciences, with a focus on social networks, behavioral science, evolution, politics, genetics, and big data.
James was recently named a Fellow of the John Simon Guggenheim Foundation, one of Foreign Policy's Top 100 Global Thinkers, TechCrunch's Top 20 Most Innovative People in Democracy, and Most Original Thinker of the year by The McLaughlin Group.
His research has been featured in numerous best-of lists including New York Times Magazine's Year in Ideas, Time's Year in Medicine, Discover Magazine's Year in Science, and Harvard Business Review's Breakthrough Business Ideas.
Together with Nicholas Christakis, James wrote a book on social networks for a general audience called Connected. Winner of a Books for a Better Life Award, it has been translated into twenty languages, named an Editor's Choice by the New York Times Book Review, and featured in Wired, Oprah's Reading Guide, Business Week's Best Books of the Year, and a cover story in New York Times Magazine.
Beatrice Alexandra Golomb, MD, PhD is Professor of Medicine, and of Family and Preventive Medicine at the University of California, San Diego; Staff Physician at the VA San Diego Healthcare Center; and has served as a Health Consultant at RAND. Her background includes a BS in physics, summa cum laude; an MD and PhD at UC San Diego (during which she gave vaulting lessons to Francis Crick); a postdoctoral fellowship in the Computational Neurobiology Laboratory at the Salk Institute, and a Robert Wood Johnson Clinical Scholarship at RAND/UCLA.
Research interests include: the balance of treatment risks and benefits; research methods and inference from evidence; and the relation of oxidative stress and mitochondrial function to health, behavior, illness, environmental and medication effects, nutrition and aging. She is best known for her work on Gulf War illness, statins, placebos – and chocolate. A number of her studies have been featured in national and international print, radio and television media, from the New York Times, Wall Street Journal, and the Economist -- to Jon Stewart’s The Daily Show
Robert A. Gunn, MD, MPH, obtained his medical degree (MD) from Yale University (1966), a Masters in Public Health (MPH) in epidemiology from UCLA (1975), and a Diploma of Tropical Medicine and Hygiene (DTM&H) from the London School of Hygiene and Tropical Medicine (1974). He is Board Certified in Preventive Medicine (1979). Dr. Gunn has worked in local, state and federal governments in public health focusing mainly on infectious disease prevention and control. He served as a Commissioned Officer in the US Public Health Service (USPHS) at the Centers for Disease Control and Prevention (CDC) and was assigned to the San Diego County Public Health Department in 1991.
Dr. Gunn joined the UCSD Department of Family and Preventive Medicine in 1993 and is currently an Adjunct Professor, Division of Preventive Medicine. He has published numerous articles about sexually transmitted infections (STDs, HIV, and viral hepatitis). His current interests involve integration of prevention services into routine medical care.
Dr. Hill is a Clinical Professor in the Department of Family and Preventive Medicine at UCSD, and the Director of the UCSD/SDSU General Preventive Medicine Residency. San Diego Family Care, a Federal 330 Community Health Center, is the site of her clinical activities, as Medical Director 1980 to 2001, and Senior Staff Physician since 2001. She is the Co-Director of the UCSD Injury Epidemiology Prevention and Research Center, and Medical Director of the Refugee Health Assessment Program. She is engaged in prevention research and teaching with current/past support from the NIH, the California Office of Traffic Safety, Robert Wood Johnson, American Cancer Society, and Health Services Resource Administration, including research in injury prevention, obesity, decision making, compliance, physician training, and refugee health. Dr. Hill serves as Chair of the Graduate Medical Education Committee for the American College of Preventive Medicine. She is a member of the American College of Preventive Medicine, the American Medical Association, the San Diego Medical Association, the Geriatric Society of America, and American Gerontology Society, and the National Physician Alliance. She is a referee on numerous journals. In addition to her teaching activities with the preventive medicine residents, she mentors and precepts medical students, masters students, pre-doctoral students and undergraduates. Her hobbies include classical piano and ocean sports.
Joachim H. Ix, MD, MAS is a nephrologist interested in the prevention of cardiovascular disease among persons with kidney disease .
His research utilizes epidemiology and biostatistics to understanding mechanisms by which alterations in glucose and mineral metabolism contribute to cardiovascular disease risk among persons with kidney disease. His recent work has focused on the consequences of altered fetuin-A concentrations, a hepatic secretory protein that simultaneously inhibits vascular calcification and promotes insulin resistance. In addition, he works with cystatin-C, a novel endogenous measure of kidney function, determining whether this measure might provide novel insights towards cardiovascular disease mechanisms among persons with early kidney function decline.
Elena Martinez, PhD, is Professor in the Department of Family and Preventive Medicine, having joined the UC San Diego faculty in 2012. She holds the Sam M. Walton Endowed Chair for Cancer Research and Co-leads the Reducing Cancer Disparities Program at the Moores Cancer Center. Dr. Martinez holds a PhD in Epidemiology and a Master’s in Public Health. Dr. Martinez’s research interests in colorectal cancer prevention began during the conduct of her doctoral dissertation and extended into her post-doctoral studies at the Harvard School of Public Health. Prior to joining the UC San Diego faculty, she was Professor of Epidemiology in the Mel and Enid Zuckerman College of Public Health and was the Richard H. Hollen Professor of Cancer Prevention at the Arizona Cancer Center. She had a very active research portfolio at the University of Arizona, including RO1 funding and program leadership in a Program Project (PO1) and a Specialized Program of Research Excellence (SPORE) program. She has published extensively in areas of epidemiology, molecular epidemiology, and cancer prevention. Her research currently focuses on breast cancer in Hispanic women, with a prominent leadership role in the Ella Binational Breast Cancer Study. She is currently co-PI of an NCI-funded UO1 grant assessing epidemiologic and epigenetic features of breast tumors occurring in the post-partum period in Hispanic women. In addition, she is a key member of the original investigative team that implemented a large Gates Foundation-funded consortium in six countries in Latin America focusing on Helicobacter pylori eradication and gastric cancer prevention. Nationally, she has established herself as a strong leader in the area of cancer health disparities; evidence of this is her appointment as recent chair of the American Association for Cancer Research Minorities in Cancer Research Council. In addition, she is senior editor of the Cancer Disparities section for the Cancer Epidemiology Biomarkers and Prevention journal. Dr. Martinez has served on the NCI’s Board of Scientific Counselors and currently she is a member of the Institute’s Board of Scientific Advisors.
Dr. Alice Mills Dr. Alice Mills is an Assistant Clinical Professor in the Department of Family and Preventive Medicine at the University of California, San Diego (UCSD). She completed her undergraduate degree in Integrative Biology at the University of California, Berkeley and her medical degree at the University of California, Irvine. She went on to receive her Family Medicine training through the Mercy Healthcare Sacramento Family Practice Residency in Sacramento, CA. Following several years in clinical practice, she returned to the University of California, Berkeley for her Masters in Public Health (Interdisciplinary Program). Most recently, she completed additional training in Preventive Medicine at UCSD through funding from the American Cancer Society.
Dr. Mills is board-certified in both Family Medicine and General Preventive Medicine. She has worked in a variety of clinical settings including HMO’s, student health centers, community clinics and health assessment programs. Her research interests include primary care medicine, general preventive medicine, cancer prevention and control, and behavioral health. Dr. Mills enjoys teaching both residents and medical students at UCSD. She is a core faculty member of the UCSD-SDSU General Preventive Medicine Residency Program and involved in teaching pre-clinical courses for medical students.
Dr. Pakiz received her doctoral degree at Harvard University and has subsequently acquired substantial experience in organizing and directing large community-based multiethnic research units in several areas of public health and disease prevention. Her research focuses on investigating effects of overweight and obesity on overall health and well-being. Dr. Pakiz has extensive experience in leading weight loss intervention groups as part of randomized clinical trials. The cognitive-behavioral therapy based intervention programs she leads focus on increasing physical activity and changing diet patterns to facilitate a modest reduction in energy intake in order to promote healthy weight management. Her research interest include examining the effects of weight loss on inflammatory cytokines which may explain the adverse effect of excess body fat on prognosis following the diagnosis of breast cancer. She is also interested in investigating the associations between weight loss and changes in psychosocial factors, including quality of life, fatigue and depression.
Based on her extensive experience in operationalizing community-based research projects, Dr. Pakiz has assisted investigators at the Cancer Prevention and Control Program with the overall conduct of a number of randomized clinical trials. Among the studies she has directed are: the SHAPE study (Survivors' Health and Physical Exercise) which tested the effects of a multifaceted weight loss program in approximately 250 overweight or obese breast cancer survivors; the Orexigen Weight Loss Study, a phase III, double-blind, placebo-controlled study which tested how much more effective an investigational new combination drug therapy can be when combined with a comprehensive lifestyle modification program in helping people lose weight and keep it off. Approximately 900 obese men and women across nine sites in the US participated in this study, including 110 subjects at UCSD; and the FAB Study (Food, Attitudes and Behavior) that tested whether participation in a commercial weight loss program is associated with a greater degree of weight loss compared to usual care or control conditions. Approximately 440 overweight or obese women across four sites in the US participated in this study, including 117 women at UCSD.
Breast Cancer, Breast Cancer Survivors, Cancer, Physical Activity, Weight Loss and Maintenance, Depression and Quality of Life
Kevin Patrick, M.D., M.S. is Professor and Editor-in-Chief of the American Journal of Preventive Medicine. He leads an interdisciplinary group researching the use of mobile and web technologies to measure and improve physical activity and diet behaviors in the context of conditions such as obesity, depression, successful aging and diabetes prevention and management. He is a Senior Advisor to the Robert Wood Johnson (RWJ) Foundation's Active Living Research program and is a member of the National Advisory Boards for RWJ's Health e-Technology and Games for Health initiatives.
Andrew Ries, M.D., M.P.H. is currently Associate Vice Chancellor for Academic Affairs and Professor of Medicine and Family and Preventive Medicine at the University of California, San Diego School of Medicine. Dr. Ries has maintained a career-long dedication to prevention and improving the health, well-being, and medical care of patients with chronic lung diseases. He directs the Pulmonary Rehabilitation Program at UCSD, one of the leading programs in the world, and has championed the cause of pulmonary rehabilitation as a standard of care for patients with disabling lung disease. He has had extensive experience in medical research directed toward improving the treatment, diagnosis, and evaluation of health outcomes in patients with chronic lung diseases. He chaired committees that published leading evidence-based guidelines reviewing and summarizing the scientific evidence establishing the basis of medical practice in pulmonary rehabilitation. He has been actively involved with state and national organizations including the American Lung Association, American Thoracic Society, American College of Chest Physicians, and American Association of Cardiovascular and Pulmonary Rehabilitation.
Dr. Rifkin is a nephrologist and epidemiologist. She received her MD degrees from Yale University and her master's in epidemiology from Tufts University. Her research interests include investigations of aging and kidney disease and issues of medication use patterns and safety in kidney disease.
Cheryl Rock, PhD, RD, is a professor in the Department of Family and Preventive Medicine, and the Cancer Prevention and Control Program, University of California, San Diego, School of Medicine. She completed undergraduate training in nutrition and dietetics at Michigan State University, achieved a Master of Medical Science degree in clinical nutrition at Emory University, and was awarded a doctoral degree in nutritional sciences from the University of California, Los Angeles.
Dr. Rock’s research efforts are focused on the role of nutritional and dietary factors in the development and progression of cancer, particularly breast cancer, and healthy weight management in adults. Her research efforts address diet composition and weight management, and how diet, adiposity and physical activity affect biomarkers and risk and progression of cancer and other chronic diseases. Dr. Rock is presently responsible for randomized trials funded by the National Institutes of Health (NIH) that are testing whether healthy weight control and modifications in diet and physical activity can alter biological processes, hormonal factors, and biomarkers of disease progression. In addition to also serving as principal investigator for an industry-sponsored randomized clinical trial of a multifaceted weight loss program, she is a co-investigator on several NIH-funded studies that are focused on obesity, various weight loss interventions, and behavioral and metabolic factors associated with disease risk. Dr. Rock also leads the Nutrition Shared Resource of the Moores UCSD Comprehensive Cancer Center, a laboratory and dietary assessment recharge service unit that is focused on identifying and measuring dietary biomarkers and improving dietary assessment methods.
Dr. Rock has served on numerous NIH and USDA review panels and committees, and she currently serves on editorial boards for several peer-reviewed journals. To date, Dr Rock is the author of more than 230 scientific papers and book chapters.
Murray B Stein MD, MPH, FRCPC is Professor of Psychiatry and Family & Preventive Medicine at the University of California San Diego (UCSD), where he directs the Anxiety & Traumatic Stress Disorders Program. Dr. Stein graduated from the University of Manitoba and completed his residency and post-residency fellowship at the University of Toronto and at the National Institute of Mental Health in Bethesda, Maryland, USA. He subsequently completed a Master of Public Health degree at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland.
DDr. Stein’s research interests include the epidemiology, neurobiology, and treatment of anxiety disorders especially social phobia, panic disorder, and posttraumatic stress disorder. He has written or co-written over 400 peer-reviewed scientific articles on these topics, including in journals such as The Lancet, Journal of the American Medical Association, American Journal of Psychiatry, and Archives of General Psychiatry. He is co-editor, with Martin Antony PhD, of the Oxford Handbook of Anxiety and Related Disorders (2009). His federally funded research has included studies of interventions for anxiety disorders in primary care, pharmacological approaches to treatment-resistant anxiety disorders, and functional neuroimaging research in anxiety and trauma-related disorders. He is Principal Investigator and Director of the Department of Defense-funded (2008-2013) INjury and TRaumatic STress (INTRuST) Consortium, which studies treatments for Posttraumatic Stress Disorder and Traumatic Brain Injury. He is also Co-Principal Investigator (with Robert Ursano MD) of Army STARRS, an NIMH-funded project (2009-2014) investigating risk factors for suicide and other deployment-related disorders.
Dr. Stein is a member of the Board of Directors of the Anxiety Disorders Association of America (ADAA), a Fellow of the American College of Neuropsychopharmacology (ACNP), Deputy Editor for Anxiety for the journal Depression & Anxiety, and Co-Editor-in-Chief for UpToDate in Psychiatry. He is a member of the editorial board of Psychological Medicine and Biological Psychiatry. Dr. Stein chaired the American Psychiatric Association Workgroup to Revise the Panic Disorder Treatment Guidelines (2006-2008), and is past Scientific Chair of the NIMH Interventions in Mood and Anxiety (ITMA) Review Group (2006-2009). Dr. Stein is a member of the DSM-5 Anxiety, Obsessive-Compulsive Spectrum, Posttraumatic, and Dissociative Disorders Work Group (2009-present). He is also a member of the Psychopharmacologic Drugs Advisory Committee (PDAC) of the Food and Drug Administration (2011-2014).